What is Seaport Res Ptn's Forecast for Innospec Q1 Earnings?

Innospec Inc. (NASDAQ:IOSP - Free Report) - Stock analysts at Seaport Res Ptn upped their Q1 2025 earnings estimates for shares of Innospec in a research report issued on Monday, February 24th. Seaport Res Ptn analyst M. Harrison now anticipates that the specialty chemicals company will earn $1.38 per share for the quarter, up from their previous forecast of $1.35. The consensus estimate for Innospec's current full-year earnings is $6.18 per share.

Separately, StockNews.com downgraded shares of Innospec from a "buy" rating to a "hold" rating in a research report on Wednesday.

Innospec Stock Down 0.6 %

NASDAQ:IOSP traded down $0.60 during trading hours on Thursday, hitting $103.41. 218,010 shares of the stock traded hands, compared to its average volume of 138,928. The company has a market cap of $2.58 billion, a price-to-earnings ratio of 72.82 and a beta of 1.09. Innospec has a 1 year low of $99.49 and a 1 year high of $133.71. The stock has a 50 day moving average price of $110.06 and a 200 day moving average price of $112.29.

Innospec (NASDAQ:IOSP - Get Free Report) last released its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.36 by $0.05. The firm had revenue of $466.80 million during the quarter, compared to analyst estimates of $447.43 million. Innospec had a net margin of 1.93% and a return on equity of 12.27%.

Remove Ads

Institutional Trading of Innospec

Several hedge funds have recently bought and sold shares of the stock. Wasatch Advisors LP lifted its stake in Innospec by 0.6% in the 3rd quarter. Wasatch Advisors LP now owns 1,805,546 shares of the specialty chemicals company's stock worth $204,189,000 after purchasing an additional 11,231 shares in the last quarter. State Street Corp lifted its stake in Innospec by 2.1% in the 3rd quarter. State Street Corp now owns 996,281 shares of the specialty chemicals company's stock worth $112,669,000 after purchasing an additional 20,744 shares in the last quarter. Victory Capital Management Inc. lifted its stake in Innospec by 1.6% in the 4th quarter. Victory Capital Management Inc. now owns 922,220 shares of the specialty chemicals company's stock worth $101,500,000 after purchasing an additional 14,188 shares in the last quarter. Royce & Associates LP lifted its stake in Innospec by 9.3% in the 3rd quarter. Royce & Associates LP now owns 835,333 shares of the specialty chemicals company's stock worth $94,468,000 after purchasing an additional 70,902 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in Innospec by 2.2% in the 4th quarter. Geode Capital Management LLC now owns 692,071 shares of the specialty chemicals company's stock worth $76,184,000 after purchasing an additional 14,788 shares in the last quarter. Hedge funds and other institutional investors own 96.64% of the company's stock.

Insider Transactions at Innospec

In other news, SVP Corbin Barnes sold 2,692 shares of Innospec stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $103.30, for a total transaction of $278,083.60. Following the sale, the senior vice president now owns 8,051 shares in the company, valued at $831,668.30. This trade represents a 25.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Philip John Boon sold 3,754 shares of the company's stock in a transaction on Friday, February 21st. The stock was sold at an average price of $103.30, for a total transaction of $387,788.20. Following the transaction, the vice president now owns 20,079 shares of the company's stock, valued at approximately $2,074,160.70. This represents a 15.75 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 7,696 shares of company stock valued at $794,853 over the last 90 days. Company insiders own 1.52% of the company's stock.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.